Product Datasheet
|
|
|
Product Description |
|
Product: |
Human coagulation Factor XII |
Catalog Number: |
HFXII |
Product Page: |
https://www.mol-innov.com/products/ |
Description: |
Human Factor XII is a single chain glycoprotein prepared from fresh human plasma by ion exchange chromatography. Factor XII is converted, principally from the action of kallikrein, into an active serine protease (Factor alpha-Xlla) that functions in the in vivo initiation of blood coagulation, fibrinolysis, and kinin formation. Purity of Factor XII is >95percent by SDS-PAGE and activity is determined via clotting assay. Prepared from plasma found negative by FDA accepted methods for Anti-HIV1/2, Anti-HTLV I & II, HBsAg, Anti-HCV, Syphilis, HBC Ab, HIV-1 p24 Ag or HIV-1 RNA, HCV RNA and HBV RNA. Donors are screened for CJD (Creutzfeldt-Jakob Disease). |
Recommended Storage: |
SAMPLE |
Minimum Shelf Life: |
308.75 |
Source: |
2.0 mg/ml |
Molecular Weight: |
Proteins |
Extinction Coefficient: |
80,000 |
Antigen: |
-70 C |
Target: |
Frozen liquid |
Target Molecular Weight: |
FACTOR XII |
Host: |
517.75 |
Clonality: |
5 |
Isotype: |
Human plasma |
Clone: |
s |
Applications: |
Dry ice |
Cross-reactivity: |
3 years from delivery |
Concentration: |
325 |
Volume: |
545 |
Titer: |
4 mM Sodium Acetate; 0.15 M NaCl; pH 5.3 |
Buffer: |
SAMPLE |
Form: |
0.5 mg |
Preservative: |
0.25 ml |
|
Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet. |
|
For in vitro laboratory use only |
|
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com |